Specific Targeting of STAT3 in B Cells Suppresses Progression of B Cell Lymphoma

The signal transducer and activator of transcription 3 (STAT3), which regulates multiple oncogenic processes, has been found to be constitutively activated in lymphoma, suggesting its potential as a therapeutic target. Here, we constructed an anti-CD19-N-(4-carboxycyclohexylmethyl) maleimide N-hydro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lipei, Zhou, Mingqian, Kong, Xiangyu, Wu, Shouzhen, Ding, Chuanlin, Hu, Xiaoling, Guo, Haixun, Yan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563066/
https://www.ncbi.nlm.nih.gov/pubmed/37686472
http://dx.doi.org/10.3390/ijms241713666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563066/
https://www.ncbi.nlm.nih.gov/pubmed/37686472
http://dx.doi.org/10.3390/ijms241713666

Ejemplares similares